The anticipated size of the DNA/RNA extraction market in 2022 was USD 1.3 billion and is estimated to be USD 1.40 billion in 2023.
The market for the global DNA/RNA extraction market is important with the rise in demand for the automation of DNA/RNA extraction technology, new user-friendly and easy extraction kits, and usage of DNA/RNA in the marking of new diseases caused by microorganisms, are expected to raise the DNA/RNA extraction kit market growth during the forecast period.
Future Market Insights has mentioned in its reports that the DNA/RNA extraction market will expand at a CAGR of 7.4% between 2023 and 2033, totaling around USD 2.85 billion by 2033. The growth of the DNA/RNA extraction market is attributed to its global utilization across the healthcare industry.
Attribute | Details |
---|---|
Projected Forecast Value (2022) | USD 1.3 billion |
Projected Forecast Value (2023) | USD 1.40 billion |
Projected Forecast Value (2033) | USD 2.85 billion |
Growth rate | 7.4% CAGR |
Forecast period | 2023 to 2033 |
DNA/RNA extraction kits are used for isolating the DNA or RNA from any cell, which can be from any animal, microbe, or plant. Primary use of these extractions is for DNA or RNA profiling of various organisms to better understand and sometimes to identify the unknown organism.
North America is considered to be a dominant region for the DNA/RNA Extraction market, driven primarily due to high Research and Development activities in the region, along with the presence of key market players in the area who are continuously evolving their product offerings for the market.
Major factors that are expected to propel the growth of the DNA/RNA Extraction Market during the forecast period include increased demand for the automation of DNA/RNA extraction technology, new user-friendly and easy extraction kits, and the use of DNA/RNA in the profiling of new diseases causing microorganisms.
Major factor that is expected to hamper the growth of the global DNA/RNA Extraction Market includes the low awareness and availability of the kits.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Global DNA/RNA extraction market grew at a CAGR of 6.35% between 2018 and 2022. Growth forecasts remain optimistic, with the market predicted to exhibit a CAGR of 7.4% between 2023 and 2033.
Rapid investments in Research and Development have increased the demand and growth of the DNA/RNA extraction kit market for various fields related equipment that included molecular diagnostics for different chronic and infectious diseases. Driven by this, the DNA/RNA extraction market will rise at 4.9% CAGR between 2021 and 2031 in comparison above the 5.3% CAGR registered during 2016-2020.
Rise in Investment in Research and Development
Major factor that is expected to propel the growth of the DNA/RNA extraction kit market during the forecast period includes increasing investments in research and development activities in different fields, including molecular diagnostics for different chronic and infectious diseases. For example, according to the Organization for Economic Co-operation and Development, in 2018, the USA spent USD 552 billion on Research and Development activities, followed by China with USD 463 billion.
Technological advancements, the launch of new products by key market players, and rising cases of cancer, globally, are other factors that may also complement the growth of the DNA/RNA Extraction market where other factors, such as increased demand for the automation of DNA/RNA extraction technology, new user-friendly and easy extraction kits, and use of DNA/RNA in the profiling of new diseases causing microorganisms, are expected to accelerate the growth of the DNA/RNA extraction kit market during the forecast period.
Factors that fuel the market include growth in funding for the research and development of extraction kits, advancement in technology, increased automation in DNA/RNA extraction technology, and an increase in demand for user-friendly products augments the growth of the market.
Low Awareness and Less Availability of Kits in the Underdeveloped and Developed Regions
Low awareness and availability of the kits and less market penetration in the underdeveloped and developing regions, globally, are the major restraining factors for the growth of the DNA/RNA extraction kit market during the forecast period.
Opportunity of Novel, Next Generation DNA Extraction Kits
Presence of unusual, next-generation DNA extraction kits is anticipated to offer important growth opportunities for competitors in the global DNA extraction kits market for example, in October 2020, Purigen Biosystems, Inc. announced the initiation of Ionic Cells to Pure DNA Low Input Kit for researchers working with limited biological samples where simplified and automated 60-minute workflow had delivered high-quality DNA for accelerated analysis of genetic abnormalities or examination of disease treatment effects.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Rise in Demand for Kits with the Rise in Prevalence for Chronic Diseases
North America is the dominant market for DNA/RNA Extraction and the trend is expected to continue into the forecast period attributed to the high Research and Development activities in the region growing at a CAGR of 26.9% along with the presence of key market players in the area who are continuously evolving their product offering for the market.
United States of America is expected to occupy the major share in the DNA/RNA extraction kit market and grows at a CAGR of 7.4% due to huge investment in Research and Development by the government and private entities, increasing demand for the kits, and rising prevalence of chronic diseases, such as cancer.
Increase in Awareness and Preference of Innovative Technologies
Europe is expected to provide immense growth opportunities for DNA/RNA Extraction, with Germany, France, and Italy expected to steer the bulk of all regional growth according to Future Market Insights with a CAGR of 17.85%.
United Kingdom DNA/RNA Extraction Market is expected to witness tremendous growth during the forecast period, owing to the increasing awareness and preference for new and innovative technologies across the region with a CAGR of 7.23%.
Economic Growth is Faring the China Market for DNA/RNA Extraction
Growth in the economy for DNA/RNA extraction has led to vast growth in the China market region with a market share of 16.9%
Presence of Innovative Biotech Companies
Japan itself being a developed nation has the presence of various innovative biotech companies that is raising their share of the market with a growth rate at a CAGR of 11.2%
Genomic DNA Isolation & Purification Kits are Said to Hold a Major Share of the Market
Genomic DNA Isolation & Purification Kits are anticipated to hold cogent growth in the near future owing to the growth in genomics-based research with a market share of 38.7%
Column-based DNA/RNA Extraction Holds a Lucrative Share in the Market
Demand for column-based extraction is high because it involves a selective bond of nucleic acid packed to a solid matrix like silica packed in a column.
Market share for column-based RNA/DNA extraction holds a share of 32.4%
DNA/RNA Extraction for Health & Diagnostics has the Dominant Share in the Market
Health and diagnostic centers dominate the market for DNA/RNA extraction market and are accounted to have the dominant revenue share of 33.6% leading to a rise in demand for early and accurate analysis of diseases.
DNA/RNA Extraction for Hospital Laboratories has a Prominent Position in the Market
DNA/RNA extraction holds a prominent position in hospital laboratories as it can be used for molecular analyses that include PCR, electrophoresis, sequencing, fingerprinting, and cloning and grows at a CAGR of 6.7%
Some of the prominent players in the global market are-
Some of the important developments of the key players in the market are:
Report Attribute | Details |
---|---|
Growth Rate | CAGR of 7.4% from 2023 to 2033 |
Market value in 2023 | USD 1.40 billion |
Market value in 2033 | USD 2.85 billion |
Base Year for Estimation | 2022 |
Historical Data | 2018 to 2022 |
Forecast Period | 2023 to 2033 |
Quantitative Units | USD billion for Value and CAGR from 2023 to 2033 |
Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
Segments Covered | By Country, By Product Type, By Method, By Application, By End user |
Regions Covered | North America; Latin America; Western Europe; Eastern Europe; Asia Pacific excluding Japan; Japan; Middle East & Africa |
Key Countries Profiled | United States, Canada, Brazil, Mexico, Rest of Latin America, Germany, United Kingdom, France, Spain, Italy, Rest of Europe, China, Japan, South Korea, Singapore, Thailand, Indonesia, Australia, New Zealand, Rest of Asia Pacific, GCC countries, South Africa, Israel, Rest of MEA |
Key Companies Profiled | Qiagen; ThermoFisher Scientific Inc.; F Hoffmann-La Roche AG; Agilent Technologies; Bio-Rad Laboratories Inc.; Promega Corporation; Danaher Corporation (Beckman Coulter Inc.); Merck & Co. Inc.; PerkinElmer Inc.; bioMérieux SA |
Customisation Scope | Available on Request |
DNA/RNA extraction market in 2033 is likely to be worth USD 2.85 billion.
DNA/RNA extraction market is expected to grow at a 7.4% CAGR during the forecast period 2023 to 2033
Sales of the DNA/RNA extraction market expanded at a CAGR of 6.35% from 2018 to 2022
Growth rate of the Japanese market for the DNA/RNA extraction market is likely to expand at a share of 11.2%
Genomic DNA Isolation & Purification Kits is expected to generate maximum demand for DNA/RNA extraction market.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Instruments 5.2. Kits & Reagents 5.2.1. Genomic DNA Isolation & Purification Kits 5.2.2. Plasmid DNA Isolation & Purification Kits 5.2.3. Viral DNA Isolation & Purification Kits 5.2.4. Total RNA Isolation & Purification Kits 5.2.5. miRNA Isolation & Purification Kits 5.2.6. mRNA Isolation & Purification Kits 5.2.7. Total Nucleic Acid (RNA + DNA) Isolation & Purification Kits 5.2.8. Sequence-specific RNA Isolation & Purification Kits 5.2.9. Viral RNA Isolation & Purification Kits 5.3. Others 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Method 6.1. Reagent-based 6.2. Column-based 6.3. Magnetic Bead-based 6.4. Other Methods 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 7.1. for Oncology 7.2. for Precision Medicine 7.3. for Health & Diagnostics 7.4. for Drug Discovery & Development 7.5. for Agriculture 7.6. for Animal Research 7.7. for Other Applications 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 8.1. for Hospital Laboratories 8.2. for Academic & Research Laboratories 8.3. for Diagnostic Laboratories 8.4. for Biopharmaceutical Companies 8.5. for Forensic Laboratories 8.6. for Contract Research Organizations 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 9.1. North America 9.2. Latin America 9.3. Western Europe 9.4. Eastern Europe 9.5. South Asia and Pacific 9.6. East Asia 9.7. Middle East and Africa 10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 17. Key Countries Market Analysis 18. Market Structure Analysis 19. Competition Analysis 19.1. Qiagen 19.2. ThermoFisher Scientific Inc. 19.3. F Hoffmann-La Roche AG 19.4. Agilent Technologies 19.5. Bio-Rad Laboratories Inc. 19.6. Promega Corporation 19.7. Danaher Corporation (Beckman Coulter Inc.) 19.8. Merck & Co. Inc. 19.9. PerkinElmer Inc. 19.10. bioMérieux SA 20. Assumptions & Acronyms Used 21. Research Methodology
Explore Healthcare Insights
View Reports